ReviewCell cycle (Georgetown, Tex.)2019
PARP3 comes to light as a prime target in cancer therapy.
José Manuel Rodriguez-Vargas et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this papercites it
ReviewCell cycle (Georgetown, Tex.)2019
José Manuel Rodriguez-Vargas et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.